It’s Never Too Soon To Translate Medical Technology Research Into a Viable Business Model. Start With Strategies Designed Specifically to Support Early-Stage Life Science Innovators.
IDENTIFY & EVALUATE POTENTIAL REIMBURSEMENT PATHWAYS
LEARN MORE AT CTIP
One of the key factors in creating a sustainable medical technology business is the strength of your reimbursement strategy.
However, medical technology incubators and accelerator programs are well aware that the road from scientific concept to clinical solution is never a straight line. That’s why — even in the earliest stages of research and development — knowledge of reimbursement realities can make a measurable difference. With expert guidance along the way, healthcare innovators can avoid costly, time-consuming missteps.
Where can accelerator programs find vital reimbursement insight?
LEARN MORE AT USC
Look to JR Associates. Our consultants provide real-world depth and perspective needed to position emerging technologies along the challenging route from bench to bedside.
Impeccable qualifications and proven results
For more than two decades, our team has been at the forefront of medical reimbursement — helping organizations from across the healthcare value chain as they navigate today’s complex, dynamic marketplace. For more than 10 years, we’ve worked in partnership with life science accelerator programs as they shape the future with biomedical breakthroughs.
LEARN MORE AT LIFEX
For example, our founder, Judy Rosenbloom, serves as reimbursement advisor to The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) and is a guest lecturer and advisor at the USC Regulatory Science Graduate Program.
Previously, Judy served as an advisor to the esteemed USC Coulter Translational Research Partnership Program and was a reviewer with the USC Stevens Center for Innovation “Ideas Empowered” Program.
In addition, our VP of Global Health Policy, Jo Ellen Slurzberg, mentors students at Harvard Business School/Harvard School of Public Health, and has served as an advisor to Harvard Innovation Labs and other translational medicine programs.
LEARN MORE AT HARVARD INNOVATION LABS
Currently, Judy and Jo Ellen also offer guidance to participants in the LifeX Labs Accelerator program for life sciences innovators who are translating their research into commercial products.
How can we help you accelerate medical technology innovation?
To learn more about how we add value in medtech accelerator environments, read our case brief:
The Power of Reframing for Reimbursement.
Or to discuss your organization’s needs, Contact Us.